vorinostat has been researched along with Cardiomyopathy, Congestive in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miksiunas, R | 1 |
| Aldonyte, R | 1 |
| Vailionyte, A | 1 |
| Jelinskas, T | 1 |
| Eimont, R | 1 |
| Stankeviciene, G | 1 |
| Cepla, V | 1 |
| Valiokas, R | 1 |
| Rucinskas, K | 1 |
| Janusauskas, V | 1 |
| Labeit, S | 1 |
| Bironaite, D | 1 |
1 other study available for vorinostat and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Cardiomyogenic Differentiation Potential of Human Dilated Myocardium-Derived Mesenchymal Stem/Stromal Cells: The Impact of HDAC Inhibitor SAHA and Biomimetic Matrices.
Topics: Aged; Biomimetics; Cardiomyopathy, Dilated; Case-Control Studies; Cell Differentiation; Cell Prolife | 2021 |